Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
EBIAT
Ratios

Bluejay Diagnostics (BJDX) Cost of Revenue (2022 - 2023)

Bluejay Diagnostics' Cost of Revenue history spans 2 years, with the latest figure at $154329.0 for Q2 2023.

  • On a quarterly basis, Cost of Revenue rose 89.69% to $154329.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $448477.0, a N/A change, with the full-year FY2024 number at $8297.0, down 97.07% from a year prior.
  • Cost of Revenue hit $154329.0 in Q2 2023 for Bluejay Diagnostics, up from $148046.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for BJDX hit a ceiling of $154329.0 in Q2 2023 and a floor of $53685.0 in Q1 2022.